8 citations as recorded by crossref.

1. Clinical controversies in the management of candidemia in adults and children D. Cluck et al. https://doi.org/10.1093/ajhp/zxag212
2. Literature review and case report on the use of rezafungin for spondylodiscitis in an outpatient parenteral antimicrobial therapy (OPAT) setting A. Richards et al. https://doi.org/10.5194/jbji-11-395-2026
3. Real-world experience with rezafungin for the treatment of biofilm-forming Candida infections M. Albanell-Fernández et al. https://doi.org/10.1080/17460913.2025.2604475
4. It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis J. Keck et al. https://doi.org/10.1007/s40121-025-01120-7
5. Salvage therapy of complicated Candida albicans spondylodiscitis with Rezafungin N. Grasselli Kmet et al. https://doi.org/10.1007/s10096-025-05117-5
6. Early use of the novel antifungal rezafungin: a case series and literature review H. Davidson et al. https://doi.org/10.1093/jac/dkaf143
7. Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States I. Reinhold et al. https://doi.org/10.1111/myc.70114
8. Antifungal activity of rezafungin in invasive candidiasis: From bench to bed G. Quindós et al. https://doi.org/10.1016/j.riam.2026.02.001